Expression of the epidermal growth factor receptor family in prostate carcinoma before and during androgen-independence

Novel palliative strategies for patients with androgen-independent prostate cancer (AIPC) include targeting the epidermal growth factor receptor (EGFR) family. The aim of the present study was to investigate intrapatient changes of EGFRs during the development of AIPC. In total, 106 symptomatic AIPC...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of cancer 2004-01, Vol.90 (2), p.449-454
Hauptverfasser:	Hernes, E, Fosså, S D, Berner, Aa, Otnes, B, Nesland, J M
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma - drug therapy Adenocarcinoma - genetics Adenocarcinoma - pathology Aged Aged, 80 and over Androgen Antagonists - pharmacology Androgens Biological and medical sciences Biomarkers, Tumor - analysis Biomedical and Life Sciences Biomedicine Biopsy Cancer Research Drug Resistance Drug Resistance, Neoplasm Epidemiology Epidermal growth factor Hospitals Humans Immunohistochemistry Male Medical research Medical sciences Middle Aged Molecular and Cellular Pathology Molecular Medicine Oncology Prostate cancer Prostatic Neoplasms - drug therapy Prostatic Neoplasms - genetics Prostatic Neoplasms - pathology Receptor, Epidermal Growth Factor - analysis Receptor, Epidermal Growth Factor - biosynthesis Receptor, Epidermal Growth Factor - genetics Retrospective Studies Survival Analysis Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!